2.5TWD
177.90 MTWD
712.99 MTWD
51.34 M
About SCIVISION BIOTECH INC
Sector
CEO
Kai Cheng Han
Website
Headquarters
Kaohsiung City
Founded
2001
ISIN
TW0001786002
FIGI
BBG001C873X6
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. Its products include dermis & joint injection, skin care cream & masks and glucosamine tablets. The company was founded on November 12, 2001 and is headquartered in Kaohsiung, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1786 is 104.0 TWD — it has decreased by 5.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SCIVISION BIOTECH INC stocks are traded under the ticker 1786.
SCIVISION BIOTECH INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SCIVISION BIOTECH INC has a max estimate of 146.0 TWD and a min estimate of 146.0 TWD.
Yes, you can track SCIVISION BIOTECH INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 1786 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCIVISION BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCIVISION BIOTECH INC EBITDA is 262.76 M TWD, and current EBITDA margin is 36.85%. See more stats in SCIVISION BIOTECH INC financial statements.